Loading people...
Kelly Nissen is a Principal at Alexandria Venture Investments, the strategic venture capital arm of Alexandria Real Estate Equities, Inc., based in the San Francisco Bay Area. In her current investment capacity, she focuses on executing early-stage equity transactions across the life sciences, biotechnology, healthcare, and agricultural technology sectors. Operating within an entity consistently recognized as one of the most active biopharma corporate venture investors globally, she evaluates emerging startup companies that align with the firm's strategic real estate and technology interests. Previously serving as an Associate within the same organization, she has developed specialized domain expertise in healthcare venture capital and complex life science real estate ecosystems. Nissen currently centers her professional efforts on identifying and funding innovative biotechnology enterprises that require specialized laboratory infrastructure to successfully advance their early-stage clinical research pipelines.
Kelly Nissen is a dedicated Associate at Alexandria Venture Investments, a leading venture capital firm renowned for its strategic investments in the life science, agtech, and technology sectors. In her role, Kelly is instrumental in the firm's investment process, contributing to the identification, evaluation, and execution of new investment opportunities. Her work directly supports Alexandria Venture Investments' commitment to fostering innovation and growth within critical industries.
At Alexandria Venture Investments, Kelly's responsibilities encompass a broad range of activities essential to venture capital operations. She conducts thorough due diligence on potential portfolio companies, analyzing market trends, competitive landscapes, and technological advancements to assess investment viability. Kelly also plays a vital role in supporting existing portfolio companies, assisting with strategic initiatives, market analysis, and operational improvements to help them achieve their milestones and maximize their impact. Her analytical skills and keen understanding of emerging technologies are crucial in navigating the complex and rapidly evolving investment landscape.
Alexandria Venture Investments has a long-standing history of backing companies that are at the forefront of scientific discovery and technological innovation. The firm's investment strategy often targets companies developing novel therapeutics, diagnostics, agricultural technologies, and disruptive tech solutions. Kelly Nissen's work aligns with this mission, as she actively seeks out ventures that demonstrate strong potential for significant societal and economic impact. While specific notable investments by an Associate are typically part of a broader team effort, Kelly contributes to the overall success of the firm's diverse portfolio, which includes numerous high-profile companies that have gone on to achieve significant breakthroughs.
Kelly's career background likely includes a strong foundation in science, finance, or a related field, providing her with the expertise necessary to evaluate complex scientific and technological propositions. Professionals in her role often bring experience from research, consulting, or other investment capacities, enabling them to effectively bridge the gap between scientific innovation and commercial success. Her dedication to identifying and nurturing promising ventures underscores Alexandria Venture Investments' reputation as a pivotal player in the venture capital ecosystem, driving progress across vital sectors.
Kelly Nissen is an Associate at Alexandria Venture Investments, a prominent venture capital firm. She is involved in identifying, evaluating, and supporting strategic investments in life science, agtech, and technology companies.
As an Associate at Alexandria Venture Investments, Kelly Nissen contributes to investments in innovative companies across the life science, agtech, and technology sectors. This includes ventures developing novel therapeutics, diagnostics, agricultural solutions, and disruptive technologies.
Kelly Nissen works at Alexandria Venture Investments. This firm is known for its strategic venture capital investments in groundbreaking life science, agtech, and technology companies.
